CTC-guided therapy beats physician choice in metastatic breast cancerDecember 15, 2022Metastatic Breast CancerBreast Cancer
Women can safely interrupt endocrine therapy to pursue pregnancyDecember 15, 2022Metastatic Breast CancerBreast Cancer
Key research on TNBC: Top five picks from SABCSDecember 15, 2022Metastatic Breast CancerBreast Cancer
Terminally ill cancer patients struggle to access psilocybinDecember 14, 2022Metastatic Breast Cancer
Capivasertib/fulvestrant improves progression free survival in breast cancerDecember 14, 2022Metastatic Breast CancerBreast Cancer
Gene signature may spare some breast cancer patients from radiationDecember 14, 2022Metastatic Breast CancerBreast Cancer
High response rates with T-DXd in early HER2-low breast cancerDecember 12, 2022Metastatic Breast CancerBreast Cancer
Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancerDecember 9, 2022Metastatic Breast CancerBreast Cancer
Chemotherapy meets its match against aggressive ER+/HER2– breast cancersDecember 9, 2022Metastatic Breast CancerBreast Cancer
Potential cause of worse outcomes among Black breast cancer patients foundDecember 9, 2022Breast CancerMetastatic Breast Cancer
Managing trastuzumab deruxtecan adverse events in the real worldDecember 1, 2022Metastatic Breast CancerBreast Cancer
Whole breast radiation for breast cancer shown to be safe and effectiveDecember 1, 2022Metastatic Breast CancerBreast Cancer
Discontinuing immunotherapy: Is the infusion bag half empty or half full?November 23, 2022Metastatic Breast Cancer
How AI is, or will soon be, relevant in radiation oncologyNovember 13, 2022Breast CancerMetastatic Breast Cancer
